EFFECT OF RENAL DENERVATION ON PLASMA RENALASE CONCENTRATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION

Objective: Renalase is an enzyme produced among others by proximal tubule cells in the kidneys and participates in the degradation of catecholamine. Results of experimental studies shown that renalase secretion is stimulated by increased plasma catecholamine concentration and by an blood pressure increase. Renal denervation (RDN), i.e., percutaneous ablation of the sympathetic nervous system fibers located in the wall of renal arteries by radio frequency waves, is a method of resistant arterial hypertension treatment. This single-center, interventional clinical study aimed to assess the effect of RDN on the plasma renalase concentration in patients with resistant arterial hypertension. Design and method: Twenty-five patients (12 women, 13 men) aged 54.4 ± 8.1 years with resistant hypertension who underwent renal denervation using Simplicity catheters (Medtronic, Inc., Northridge, CA) were enrolled in the study. Plasma renalase concentration was determined by enzyme-linked immunosorbent assay method (Cloud-Clone Corp., Houston, TX, USA) before RDN, 6 and 12 months after RDN. Results were presented as a mean with standard deviation. Results: Systolic, diastolic blood pressure and heart rate were reduced after RDN (before RDN, 6 and 12 months after RDN, respectively: 190.4 ± 25.0, 161.1 ± 14.7, 155.5 ± 18.3; p<0.001; and 111.8 ± 19.3, 88.9 ± 8.5, 91.0 ± 10.4 mmHg; p<0.001 and 80.1 ± 16.3, 74.5 ± 11.1, 73.6 ± vs. 11.3 beats/min; p<0.001). Plasma renalase concentrations measured before RDN, 6 and 12 months after RDN in the whole studied group were 25.1 ± 7.5, 22.0 ± 7.1, and 23.1 ± 6.0 [μg/mL], respectively (ANOVA p<0.001, Fisher post hoc: before vs. six months p = 0.01, before vs. 12 months p = 0.09, six months vs. 12 months p = 0.3). There were no significant correlations between changes of plasma renalase concentration and decrease of blood pressure and heart rate during the follow-up after RDN. Conclusions: 1. Renal denervation decreases moderate plasma renalase concentration, however this effect of RDN seems to be not associated with observed decrease of blood pressure. 2. Further studies are required to evaluate whether decrease in plasma renalase concentration is associated with change in plasma catecholamine concentration.

Authors

Institutions

Publication Details

Journal
Journal of Hypertension
Published
2025-05-01
DOI
https://doi.org/10.1097/01.hjh.0001116428.25097.5d
Primary Topic
Cardiovascular Health and Disease Prevention
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EFFECT OF RENAL DENERVATION ON PLASMA RENALASE CONCENTRATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION

Damian Gojowy, Katarzyna Mizia­‐Stec, Andrzej Więcek, Michał Lelek et al.
Journal of Hypertension
Cardiovascular Health and Disease Prevention
article

EFFECT OF RENAL DENERVATION ON PLASMA RENALASE CONCENTRATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION

Damian Gojowy, Katarzyna Mizia­‐Stec, Andrzej Więcek, Michał Lelek, Marcin Adamczak, Beata Czerwieńska
article en

Abstract

Objective: Renalase is an enzyme produced among others by proximal tubule cells in the kidneys and participates in the degradation of catecholamine. Results of experimental studies shown that renalase secretion is stimulated by increased plasma catecholamine concentration and by an blood pressure increase. Renal denervation (RDN), i.e., percutaneous ablation of the sympathetic nervous system fibers located in the wall of renal arteries by radio frequency waves, is a method of resistant arterial hypertension treatment. This single-center, interventional clinical study aimed to assess the effect of RDN on the plasma renalase concentration in patients with resistant arterial hypertension. Design and method: Twenty-five patients (12 women, 13 men) aged 54.4 ± 8.1 years with resistant hypertension who underwent renal denervation using Simplicity catheters (Medtronic, Inc., Northridge, CA) were enrolled in the study. Plasma renalase concentration was determined by enzyme-linked immunosorbent assay method (Cloud-Clone Corp., Houston, TX, USA) before RDN, 6 and 12 months after RDN. Results were presented as a mean with standard deviation. Results: Systolic, diastolic blood pressure and heart rate were reduced after RDN (before RDN, 6 and 12 months after RDN, respectively: 190.4 ± 25.0, 161.1 ± 14.7, 155.5 ± 18.3; p<0.001; and 111.8 ± 19.3, 88.9 ± 8.5, 91.0 ± 10.4 mmHg; p<0.001 and 80.1 ± 16.3, 74.5 ± 11.1, 73.6 ± vs. 11.3 beats/min; p<0.001). Plasma renalase concentrations measured before RDN, 6 and 12 months after RDN in the whole studied group were 25.1 ± 7.5, 22.0 ± 7.1, and 23.1 ± 6.0 [μg/mL], respectively (ANOVA p<0.001, Fisher post hoc: before vs. six months p = 0.01, before vs. 12 months p = 0.09, six months vs. 12 months p = 0.3). There were no significant correlations between changes of plasma renalase concentration and decrease of blood pressure and heart rate during the follow-up after RDN. Conclusions: 1. Renal denervation decreases moderate plasma renalase concentration, however this effect of RDN seems to be not associated with observed decrease of blood pressure. 2. Further studies are required to evaluate whether decrease in plasma renalase concentration is associated with change in plasma catecholamine concentration.

Journal of HypertensionVol. 43(Suppl 1)
Medical University of Silesia (PL)
Good health and well-being
Openalex Percentile: Top 80%
Cardiovascular Health and Disease Prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.